Implementing IntelliCare in Collaborative Care: A Quality Improvement Evaluation
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- Adaptive Health, Inc
- Enrollment
- 318
- Locations
- 1
- Primary Endpoint
- Depression
- Status
- Terminated
- Last Updated
- 4 years ago
Overview
Brief Summary
The overarching aim of the proposed project is to conduct a pragmatic, quality improvement evaluation of the IntelliCare Platform for improving processes of care in the Rush Collaborative Care program, and improving patient population depression outcomes, to determine the long-term utility of IntelliCare for Rush.
Detailed Description
This study is a pragmatic, system-wide rollout quality improvement evaluation design displayed in Figure 1. The Rush IRB has waived consent for this quality improvement trial. Data from the EHR will be used beginning December 1, 2019. The first care manager (CM) will begin enrolling patients into IntelliCare in September, 2020. Additional CMs will begin using IntelliCare at approximately 3 month intervals. In September 2021, support for IntelliCare from the evaluation team will be withdrawn, to examine the sustainability of the IntelliCare Platform. Patients Data from all patients, aged 18 or older, enrolled collaborative care from December 1, 2019 through August 31, 2022 will be used to evaluate the IntelliCare service. All CCT patients who are 18 or older, and have a smartphone will be offered enrollment.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Enrolled in Rush Collaborative Care service
- •Owns a personal smartphone
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Depression
Time Frame: Up to 20 Months
Patient Health Questionnaire-9 (PHQ-9) assessment for depression
Number of assessments
Time Frame: Up to 20 Months
Number of Patient Health Questionnaire (PHQ-9) assessments acquired in the EHR
Secondary Outcomes
- First to last assessment(Up to 20 Months)